G. Shao

发表

Monitoring Breast Tumor Lung Metastasis by U-SPECT-II/CT with an Integrin αvβ3-Targeted Radiotracer 99mTc-3P-RGD2

Yang Zhou, G. Shao, Shuang Liu, 2012, Theranostics.

(99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.

Yan Li, G. Shao, YingJian Zhang, 2014, Cancer biotherapy & radiopharmaceuticals.

Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.

Yang Zhou, G. Shao, Feng Wang, 2013, Molecular imaging.

99m Tc-Labeled Cyclic RGD Peptide Dimer Useful for Tumor Imaging

Shun-dong Ji, Yang Zhou, G. Shao, 2013 .

Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment.

Yueming Sun, G. Shao, Peng Yang, 2021, Biomaterials science.

³²P-chromic phosphate-Poly(L-Lactide) seeds of sustained release and their brachytherapy for prostate cancer with lymphatic metastasis.

Peilin Huang, Luwei Xu, Wen-cheng Li, 2012, Cancer biotherapy & radiopharmaceuticals.

Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.

Shuang Liu, Shun-dong Ji, Yang Zhou, 2013, Bioconjugate chemistry.

99mTc-Galacto-RGD2 Integrin αvβ3 Targeted Imaging as a Surrogate for Molecular Phenotyping in Lung Cancer: Prospective Study in the Real World

G. Shao, T. Fu, Wei Qu, 2021 .

Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2

D. Albert, G. Fox, Shun-dong Ji, 2013, The Journal of Pharmacology and Experimental Therapeutics.

(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.

P. Sowiński, Shun-dong Ji, Yang Zhou, 2013, Molecular pharmaceutics.

[Positive rate and accuracy of ultrasound-guided fine-needle aspiration cytology for detecting suspected thyroid carcinoma nodules of different sizes].

W. Yang, Jinfeng Li, G. Shao, 2020, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[Theranostics of osteosarcoma and lung metastasis with new integrin α vβ 3 receptor targeted radiotracers].

Liming Wang, G. Shao, Q. Yao, 2019, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery.

Copolymer-Based Hepatocyte Asialoglycoprotein Receptor Targeting Agent for SPECT

G. Shao, Feng Wang, Xianzhong Zhang, 2011, The Journal of Nuclear Medicine.

Detection of Bone Metastases by 68Ga-DOTA-SSAs and 18F-FDG PET/CT: A Two-Center Head-to-Head Study of Gastroenteropancreatic Neuroendocrine Neoplasms

G. Shao, Feng Wang, F. Yu, 2022, Contrast media & molecular imaging.

Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy

Peilin Huang, G. Shao, Feng Wang, 2018, Contrast media & molecular imaging.

Antitumor effects of 32P-chromic-poly (L-lactide) brachytherapy in nude mice with human prostate cancer

G. Shao, Zizheng Wang, Xi-shan Zhu, 2013, Oncology letters.

Preliminary study of the biodegradation and the correlation between in vitro and in vivo release of (32)P-chromic phosphate-poly(L-lactide) seeds.

Yanlong Su, G. Shao, Zizheng Wang, 2013, Cancer biotherapy & radiopharmaceuticals.

68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients

R. Jia, G. Shao, Zi-chun Hua, 2017, Oncotarget.

Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.

Ming-Rong Zhang, Lin Xie, A. Hatori, 2017, American journal of nuclear medicine and molecular imaging.

68Ga-DOTA-NT-20.3 Neurotensin Receptor 1 PET Imaging as a Surrogate for Neuroendocrine Differentiation of Prostate Cancer

G. Shao, Hongqian Guo, Shuyue Ai, 2022, The Journal of Nuclear Medicine.

Triple-phase 99mTc-3P-RGD2 imaging of peripheral primitive neuroectodermal tumor in the hip muscle group with bone metastasis.

G. Shao, Feng Wang, Jingjing Fu, 2017, Molecular and clinical oncology.

In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens.

D. Ding, G. Shao, Zongjin Li, 2019, ACS nano.

Integrin αvβ3-Targeted Radiotracer 99mTc-3P-RGD2 Useful for Noninvasive Monitoring of Breast Tumor Response to Antiangiogenic Linifanib Therapy but not Anti-Integrin αvβ3 RGD2 Therapy

Shun-dong Ji, Yang Zhou, G. Shao, 2013, Theranostics.

Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis

G. Shao, Shuang Liu, Feng Wang, 2017, Oncotarget.

DNA origami: an outstanding platform for functions in nanophotonics and cancer therapy.

Peng Liu, G. Shao, Xiaozhi Zhao, 2021, The Analyst.

Preparation of 68Ga-PSMA-11 with a Synthesis Module for Micro PET-CT Imaging of PSMA Expression during Prostate Cancer Progression

Jian-ping Wu, R. Jia, G. Shao, 2018, Contrast media & molecular imaging.

177Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians

R. Jia, G. Shao, Hongqian Guo, 2022, Frontiers in Oncology.

Preparation of 68Ga-PSMA-11 with a Synthesis Module for Micro PET-CT Imaging of PSMA Expression during Prostate Cancer Progression

Jian-ping Wu, R. Jia, G. Shao, 2018, Contrast media & molecular imaging.

Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin αvβ3–Targeted Radiotracer 99mTc-3P-RGD2

D. Albert, G. Fox, Shun-dong Ji, 2013, Journal of Pharmacology and Experimental Therapeutics.

Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy

Peilin Huang, G. Shao, Feng Wang, 2018, Contrast media & molecular imaging.

Study on Bone Density at Various Skeletal Sites for the Diagnosis of Primary Osteoporosis

G. Shao, Feng Wang, Zizheng Wang, 2012, Cell Biochemistry and Biophysics.

Deep learning based on 68Ga-PSMA-11 PET/CT for predicting pathological upgrading in patients with prostate cancer

G. Shao, Feng Wang, Jingjing Fu, 2024, Frontiers in oncology.